COST-EFFECTIVENESS OF COMBINATION THERAPY WITH DUTASTERIDE/TAMSULOSIN- AN ANALYSIS BASED ON CONDUCT TRIAL

Author(s)

Vallejo-Aparicio LA1, Miñana López B2, Brenes FJ3, Molero JM4, Fernández-Pro A5, Huerta A1, Cozar JM6
1GlaxoSmithKline, Tres Cantos (Madrid), Spain, 2Hospital General Universitario J.M. Morales Meseguer, Murcia, Spain, 3CAP Badalona-6 Llefià Badalona, Barcelona, Spain, 4Centro de Salud San Andrés, Madrid, Spain, 5Centro de Salud de Menasalbas, Toledo, Spain, 6Hospital Universitario Virgen de las Nieves, Granada, Spain

OBJECTIVES:  

Conference/Value in Health Info

2016-10, ISPOR Europe 2016, Vienna, Austria

Value in Health, Vol. 19, No. 7 (November 2016)

Code

PUK13

Topic

Economic Evaluation

Topic Subcategory

Cost-comparison, Effectiveness, Utility, Benefit Analysis

Disease

Urinary/Kidney Disorders

Explore Related HEOR by Topic

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×